Pfizer targets Newcastle
May 15, 2013Research and Development, Sales and Marketing ABPI, Cameron, NHS, Newcastle, Pfizer
Pfizer has earmarked Newcastle Hospitals NHS Foundation Trust as one of 60 sites worldwide to take part in a key …
Amgen and Zhejiang sign cancer deal
May 14, 2013Sales and Marketing Amgen, Cancer, Zhejiang
Amgen has signed a joint venture deal with Chinese firm Zhejiang Beta Pharma to commercialise oncology drug Vectibix. The companies …
Optimer Pharmaceuticals appoints chief operating officer
May 14, 2013Manufacturing and Production, Research and Development, Sales and Marketing
Biopharma firm Optimer Pharmaceuticals has announced the appointment of Eric Sirota as chief operating officer. “Eric has tremendous experience and …
Ranbaxy unit fined $500m for selling adulterated drugs
May 14, 2013Manufacturing and Production FDA, GMP, Ranbaxy, fine, generics
Ranbaxy’s US subsidiary has agreed to pay fines and penalties totalling $500 million after pleading guilty to charges of manufacturing …
EMA ponders biosimilar guideline
May 14, 2013Research and Development, Sales and Marketing EMA, biosimilars
The European Medicines Agency is thinking about changes to its guidance on similar biological medicines and has published a draft …
Lilly takes $30m hit
May 13, 2013Research and Development, Sales and Marketing enzastaurin, lilly
Eli Lilly has taken a $30 million hit after abandoning late-stage development of its investigational cancer drug enzastaurin. The compound …
Francis at centre of Care Bill
May 13, 2013Sales and Marketing Hunt, Mid Staffs, NHS
The government’s new Care Bill carries a variety of measures designed to ensure that failings such as those at the …
John LaMattina: India’s solution to drug costs
May 13, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing India, LaMattina, R&D
Drug pricing is a major issue in India. The Indian government believes that the prices of lifesaving drugs shouldn’t be …
New Board member for Misonix
May 13, 2013Manufacturing and Production, Research and Development, Sales and Marketing Misonix
Surgical device company Misonix has announced that Stavros Vizirgianakis has been appointed to its Board of directors.The addition of Vizirgianakis …
Takeda to buy Inviragen
May 10, 2013Research and Development, Sales and Marketing Inviragen, Takeda
Takeda has hit the acquisition trail, putting together a $250 million package to buy private US biopharma firm Inviragen in …
Government confirms NHS ‘free’
May 10, 2013Sales and Marketing Hunt, NHS, avaaz
The government has reaffirmed that NHS treatment “will remain free at the point of delivery and available according to clinical …
Egalet appoints Stan Musial as CFO
May 10, 2013Manufacturing and Production, Research and Development, Sales and Marketing Egalet, musial
Speciality pharma firm Egalet has announced the appointment of Stan Musial as chief financial officer. Bob Radie, president and chief …
Dyadic International hires chief operating officer
May 10, 2013Manufacturing and Production, Research and Development, Sales and Marketing dyadic
Biotech firm Dyadic International has appointed Danai Brooks to the role of executive VP and chief operating officer. Starting in …
New Viagra site launched
May 10, 2013Manufacturing and Production, Medical Communications, Sales and Marketing ED, Pfizer, viagra
Pfizer has launched a new sales website for Viagra, the ‘little blue pill’ which is its most counterfeited medicine, to …
Aesica forges alliance with UK university on API synthesis
May 8, 2013Manufacturing and Production Aesica
UK contract manufacturing organisation (CMO) Aesica has teamed up with the University of Nottingham to develop new ways to form …
Manufacturing facility news in brief
May 8, 2013Manufacturing and Production Expeditors, Novo Nordisk, Penn Pharma, Sagent Pharma, Vertellus
A round-up of new facility developments in the pharma sector, including updates from Novo Nordisk, Sagent, Penn Pharma, Vertellus and …
VBP will be ‘unfair’: report
May 8, 2013Medical Communications, Research and Development, Sales and Marketing 2020health, ABPI, NHS, VBP
A new report on value-based pricing (VBP) concludes that the new system will be unfair to patients and says the …
AstraZeneca reveals Alderley Park plan
May 8, 2013Research and Development, Sales and Marketing AstraZeneca, BioCity, R&D, alderley
AstraZeneca has left a key question about what to do with its soon-to-be defunct R&D site in Cheshire in the …
New UK head at Porter Novelli
May 8, 2013Medical Communications, Sales and Marketing Porter Novelli, smiddy
PR firm Porter Novelli has announced that Mary Smiddy has been named as its new UK head of health & …
Asian regulators take issue with J&J facilities
May 7, 2013Manufacturing and Production India, J&J, JJ, Korea, inspection
Johnson & Johnson’s manufacturing network is under yet more scrutiny following regulatory actions by authorities in India and South Korea. …
Latest content
Five Facts about NHS and primary care
AI in pharma: From lab development to patient impact
